Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sandra R. Wadlinger"'
Autor:
Beatriz L. Rodriguez, Jack Moye, Elizabeth Barksdale Boyle, Omar A. Abdul-Rahman, Jeffrey R. Botkin, Sandra R. Wadlinger, Lori S. Merrill, Julia Slutsman
Publikováno v:
Birth Defects Research Part A: Clinical and Molecular Teratology. 106:47-54
Background The National Children's Study (NCS) Vanguard Study began enrollment in January 2009 as an initial pilot study for a planned large-scale, longitudinal U.S. cohort study of the effect of environmental influences on child health and developme
Autor:
Sandra R. Wadlinger, Sharon B. Wyatt, Donald J. Dudley, Simone A. Reynolds, Daniel E. Hale, Debra Cherry, Cheryl K. Walker, Stephen L. Buka, Gwendolyn S. Norman, Kendall K. Cislo, James M. Robbins, Anna Maria Siega-Riz, Pearl A. McElfish
OBJECTIVE: In 2009, the National Children’s Study (NCS) Vanguard Study tested the feasibility of household-based recruitment and participant enrollment using a birth-rate probability sample. In 2010, the NCS Program Office launched 3 additional rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a665fa53ffb62218497f3ad1978a3f8d
Autor:
Dan L. Stewart, David J. Durand, Richard J. Martin, Avital Cnaan, Mark L. Hudak, Roberta A. Ballard, Dennis E. Mayock, Philip L. Ballard, Sandra R. Wadlinger, Eric C. Eichenwald, Asha R. Puri, Jeffrey D. Merrill, Sergio G. Golombek, Stephen E. Welty, Michele C. Walsh, Anna Maria Hibbs, Roderic H. Phibbs, Donald R. Null, William E Truog, Jeanette M. Asselin, Christine E. Coburn, Sherry E. Courtney, Xianqun Luan
Publikováno v:
New England Journal of Medicine. 355:343-353
Bronchopulmonary dysplasia in premature infants is associated with prolonged hospitalization, as well as abnormal pulmonary and neurodevelopmental outcome. In animal models, inhaled nitric oxide improves both gas exchange and lung structural developm
Autor:
Philip L. Ballard, William E Truog, Roberta A. Ballard, Sandra R. Wadlinger, Anna Maria Hibbs, Avital Cnaan, John A.F. Zupancic, Lisa Palermo, Dennis M. Black
Publikováno v:
Pediatrics. 124(5)
OBJECTIVE: In the previously reported Nitric Oxide for Chronic Lung Disease (NO CLD) trial, ventilated preterm infants who received a course of inhaled nitric oxide (iNO) between 7 and 21 days of life had a significant improvement in survival without
Autor:
Richard K. Miller, Sandra R. Wadlinger, Jennifer F. Culhane, Phillip J. Landrigan, Lisa Littman, James M. Swanson, P. Sheffield, C. Torres, Ronald J. Wapner, Maureen S. Durkin, Dawn P. Misra, N. Thieux, Christopher J. Stodgell, John Moye, S. Leuthner, Sara Szabo, Carolyn Salafia, Philip J. Katzman, B. Specker, Luis I. Ruffolo
Publikováno v:
Placenta. 34:A14-A15
s / Placenta 34 (2013) A1–A99 A14 structural complexity (Figure 2) Microscopic review confirmed differences in the numbers, sizes and shapes of villi (Figure 3 ASD, Figure 4 control). Conclusions: These preliminary data represent our second test of
Two-Year Neurodevelopmental Outcomes of Ventilated Preterm Infants Treated with Inhaled Nitric Oxide
Autor:
Eric Vittinghoff, Roberta A. Ballard, William E Truog, Anna Maria Hibbs, Michele C. Walsh, Avital Cnaan, Sandra R. Wadlinger, Roberta L. Keller, Christine E. Coburn, Camilia R. Martin, Arlene Zadell, Philip L. Ballard, Richard J. Martin
Publikováno v:
The Journal of Pediatrics. 156:556-561.e1
In a randomized multi-center trial, we demonstrated that inhaled nitric oxide begun between 7 and 21 days and given for 24 days significantly increased survival without bronchopulmonary dysplasia (BPD) in ventilated premature infants weighing1250 g.
Autor:
Sandra R. Wadlinger, Evaline A. Alessandrini, Philip L. Ballard, Anna Maria Hibbs, Avital Cnaan, Scott A. Lorch, Roberta A. Ballard, Christine E. Coburn, William E Truog, Lisa Palermo, Richard J. Martin, Michele C. Walsh
Publikováno v:
The Journal of Pediatrics. 153:525-529.e2
Objective To identify whether inhaled nitric oxide treatment decreased indicators of long-term pulmonary morbidities after discharge from the neonatal intensive care unit. Study design The Nitric Oxide (to Prevent) Chronic Lung Disease trial enrolled